These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7946456)

  • 1. Local production of plasminogen activator inhibitor-1 in carcinomatous pleuritis.
    Satoh H; Kamma H; Ogata T; Hasegawa S
    Acta Oncol; 1994; 33(6):710-1. PubMed ID: 7946456
    [No Abstract]   [Full Text] [Related]  

  • 2. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
    Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
    Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships among tumor burden, tumor size, and the changing concentrations of fibrin degradation products and fibrinolytic factors in the pleural effusions of rabbits with VX2 lung tumors.
    Hatton MW; Southward SM; Ross BL; Clarke BJ; Singh G; Richardson M
    J Lab Clin Med; 2006 Jan; 147(1):27-35. PubMed ID: 16443002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status of lipid peroxidation and antioxidant enzymes in malignant (bronchogenic carcinoma) and non-malignant pleural effusions.
    Vanisree AJ; Shyamaladevi CS
    Indian J Cancer; 1999; 36(2-4):127-34. PubMed ID: 10921216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of soluble interleukin 2 receptor in differentiating tuberculous and carcinomatous pleural effusions.
    Chang SC; Hsu YT; Chen YC; Lin CY
    Arch Intern Med; 1994 May; 154(10):1097-101. PubMed ID: 8185423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of soluble interleukin 2 receptor alpha in the pleural fluid].
    Ni SS; Gao ZL
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(2):81-2, 123. PubMed ID: 8221956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of malignant pleural effusion by multimodality treatment including the use of paclitaxel administered by 24-hour intrathoracic infusion for patients with carcinomatous pleuritis.
    Ohta Y; Shimizu Y; Matsumoto I; Watanabe G
    J Exp Clin Cancer Res; 2006 Mar; 25(1):15-9. PubMed ID: 16761613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion.
    Yeh HH; Lai WW; Chen HH; Liu HS; Su WC
    Oncogene; 2006 Jul; 25(31):4300-9. PubMed ID: 16518408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleural effusion and serum soluble fas-ligand levels are elevated in different clinical conditions.
    Wang PS; Chen YM; Hsieh YL; Yu CF; Tsai CM; Perng RP
    Lung; 2002; 180(1):25-32. PubMed ID: 12105754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of copper and ceruloplasmin levels in effusions of malignant and benign origin.
    Yenisey C; Fadiloğlu M; Onvural B; Erer FO
    Biochem Soc Trans; 1995 Nov; 23(4):606S. PubMed ID: 8654791
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential role of human visceral pleura in pleural fluid turnover.
    Gao ZC; Xue PL; Zhang Y; Shen DH; Wang J; He QY
    Chin Med J (Engl); 2006 Feb; 119(3):250-4. PubMed ID: 16537016
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of plasminogen activator inhibitors 1 and 2 in lung cancer and their role in tumor progression.
    Robert C; Bolon I; Gazzeri S; Veyrenc S; Brambilla C; Brambilla E
    Clin Cancer Res; 1999 Aug; 5(8):2094-102. PubMed ID: 10473092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated soluble CD26 levels in patients with tuberculous pleurisy.
    Oshikawa K; Sugiyama Y
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):868-72. PubMed ID: 11573900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of c-c chemokines in the determination of pleural effusion etiology].
    Trzaska-Sobczak M; Pierzchała W; Brozek G; Farnik M
    Wiad Lek; 2008; 61(7-9):190-4. PubMed ID: 19172830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of prostaglandin E2 in the invasiveness, growth and protection of cancer cells in malignant pleuritis.
    Pace E; Siena L; Ferraro M; Profita M; Mondello P; Chiappara G; Montalbano AM; Giarratano A; Bonsignore G; Gjomarkaj M
    Eur J Cancer; 2006 Sep; 42(14):2382-9. PubMed ID: 16899364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of etoposide after intrathoracic instillation to lung cancer patients with pleural effusion.
    Wada I; Yokouchi M; Saitoh H; Takada M; Nakabayashi T; Mino K; Honma T; Takeda T; Hirano K
    Int J Clin Pharmacol Ther; 1999 May; 37(5):254-9. PubMed ID: 10363625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic utility of carcinoembryonic antigen, neuron-specific enolase and squamous cell carcinoma antigen in malignant pleural effusion].
    Sánchez de Cos Escuín J; López Parra S; Disdier Vicente C; Martín Vicente MJ; Masa Jiménez JF; Domínguez Retortillo C
    An Med Interna; 1996 Aug; 13(8):369-73. PubMed ID: 8983362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model.
    Soff GA; Sanderowitz J; Gately S; Verrusio E; Weiss I; Brem S; Kwaan HC
    J Clin Invest; 1995 Dec; 96(6):2593-600. PubMed ID: 8675623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystatin C of pleural effusion as a novel diagnostic aid in pleural diseases of different aetiologies.
    Domej W; Tilz GP; Földes-Papp Z; Demel U; Rabold T; Holzer H
    Clin Sci (Lond); 2002 Mar; 102(3):373-80. PubMed ID: 11869179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The difference between carcinomatous and tuberculous pleural fluid in fibrin and fibrinogen metabolism (author's transl)].
    Suzuki S; Kanayama M; Miura H; Shimase J; Matsui N
    Rinsho Ketsueki; 1981 Feb; 22(2):186-93. PubMed ID: 7310987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.